Kategorien
Aktien

Boston Scientific

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US101137AT41
USD
  • Boston Scientific Corporation
    Börse NYSE New York Stock Exchange
    ISIN US101137AT41
    USD
  • ISIN US101137AU14
    MXN
  • ISIN US101137AS67
    USD
  • ISIN US101137AW79
    BRL
ISIN US101137AT41

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von

65 News & Informationen zur Boston Scientific Aktie

  • Bronchoscopy Market to Reach $4.88 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research
    markets.businessinsider.com

    Bronchoscopy Market to Reach $4.88 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research

    PORTLAND, Ore., Aug. 10, 2021 /PRNewswire/ — Allied Market Research published a report, titled, 'Bronchoscopy Market by Product (Endoscope, Visua…

  • Bronchoscopy Market to Reach $4.88 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research
    markets.businessinsider.com

    Bronchoscopy Market to Reach $4.88 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research

    – Increase in prevalence of respiratory diseases and growth in demand for minimally invasive surgery, drive the growth of the global bronchoscopy …

  • Insights on the Peripheral Vascular Devices Global Market to 2026 - by Type, End-users and Geography
    prnewswire.com

    Insights on the Peripheral Vascular Devices Global Market to 2026 – by Type, End-users and Geography

    /PRNewswire/ — The

  • The Worldwide Urology Care Devices and Platforms Industry is Expected to Reach $33.64 Billion by 2030
    markets.businessinsider.com

    The Worldwide Urology Care Devices and Platforms Industry is Expected to Reach $33.64 Billion by 2030

    DUBLIN, Aug. 9, 2021 /PRNewswire/ — The 'Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End Us…

  • Smart Pills Global Market Report 2021: COVID-19 Growth and Changes to 2030
    markets.businessinsider.com

    Smart Pills Global Market Report 2021: COVID-19 Growth and Changes to 2030

    DUBLIN, Aug. 6, 2021 /PRNewswire/ — The 'Smart Pills Global Market Report 2021: COVID-19 Growth and Change to 2030' report has been added to Rese…

  • MRM Named By Fast Company As One Of The 100 Best Places To Work For Innovators
    markets.businessinsider.com

    MRM Named By Fast Company As One Of The 100 Best Places To Work For Innovators

    NEW YORK, Aug. 4, 2021 /PRNewswire/ — MRM, the leading marketing agency that is part of McCann Worldgroup, announced today it has been named to F…

  • MRM Named By Fast Company As One Of The 100 Best Places To Work For Innovators
    prnewswire.com

    MRM Named By Fast Company As One Of The 100 Best Places To Work For Innovators

    /PRNewswire/ — MRM, the leading marketing agency that is part of McCann Worldgroup, announced today it has been named to Fast Company's Third Annual list of…

  • Top Research Reports for Amazon, Pfizer & Verizon
    zacks.com

    Top Research Reports for Amazon, Pfizer & Verizon

    Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Pfizer Inc. (PFE), and Verizon Communications Inc. (VZ).

  • Global Wearable Medical Devices Market Report 2021-2026 Featuring Major Players - Apple, Abbott Laboratories, Dexcom, Fitbit, LG Electronics
    thestreet.com

    Global Wearable Medical Devices Market Report 2021-2026 Featuring Major Players – Apple, Abbott Laboratories, Dexcom, Fitbit, LG Electronics

    DUBLIN, July 30, 2021 /PRNewswire/ — The “Global Wearable Medical Devices Market By Product Type (Activity Monitors/Trackers, Smartwatches, Patches, Smart

  • Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
    fool.com

    Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript

    BSX earnings call for the period ending June 30, 2021.

  • Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q2 2021 Results – Earnings Call Transcript

    Boston Scientific Corporation (NYSE:BSX) Q2 2021 Earnings Conference Call July 27, 2021 08:00 AM ET Company Participants Lauren Tengler – Vice President, Investor Relations Michael Mahoney…

  • Boston Scientific (BSX) Q2 Earnings Beat, 2021 Guidance Up
    zacks.com

    Boston Scientific (BSX) Q2 Earnings Beat, 2021 Guidance Up

    Organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in Q2.

  • Stocks That Hit 52-Week Highs On Tuesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Tuesday

    This morning 85 companies set new 52-week highs.
    Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet …

  • Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
    zacks.com

    Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates

    Boston Scientific (BSX) delivered earnings and revenue surprises of 8.11% and 4.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Boston Scientific tops Q2 forecast; raises FY21 guidance (NYSE:BSX)
    seekingalpha.com

    Boston Scientific tops Q2 forecast; raises FY21 guidance (NYSE:BSX)

    Boston Scientific (BSX) reports consensus beating financial results for Q2 ended June 30, 2021.Net sales for Q2 rose 53.6% on reported basis to $3.08B vs

  • Boston Scientific Corp. Stock Quote (U.S.: NYSE)
    marketwatch.com

    Boston Scientific Corp. Stock Quote (U.S.: NYSE)

    BSX | Complete Boston Scientific Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  • Boston Scientific EPS beats by $0.03, beats on revenue, raises FY21 outlook (NYSE:BSX)
    seekingalpha.com

    Boston Scientific EPS beats by $0.03, beats on revenue, raises FY21 outlook (NYSE:BSX)

    Boston Scientific (BSX): Q2 Non-GAAP EPS of $0.40 beats by $0.03; GAAP EPS of $0.12 misses by $0.09.Revenue of $3.07B (+53.5% Y/Y) beats by $130M.FY21 Guidance: The company now…

  • Earnings Scheduled For July 27, 2021
    benzinga.com

    Earnings Scheduled For July 27, 2021

    Companies Reporting Before The Bell
    • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on …

  • Tuesday Morning’s Earnings
    investing.com

    Tuesday Morning’s Earnings

    Stocks Analysis by Tim Knight covering: 3M Company, Sherwin-Williams Co, General Electric Company, United Parcel Service Inc. Read Tim Knight's latest article on Investing.com

  • WOCHENVORSCHAU: Termine bis 09. August 2021
    finanzen.net

    WOCHENVORSCHAU: Termine bis 09. August 2021

    WOCHENVORSCHAU: Termine bis 09. August 2021 | Nachricht | finanzen.net

  • Patient Monitoring Devices Market worth $ 30.59 Billion, Globally, by 2028 at 5.34% CAGR: Verified Market Research™
    prnewswire.com

    Patient Monitoring Devices Market worth $ 30.59 Billion, Globally, by 2028 at 5.34% CAGR: Verified Market Research™

    /PRNewswire/ — Verified Market Research recently published a report, “Patient Monitoring Devices Market” By Product (Blood Glucose Monitoring Systems, Cardiac…

  • The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
    markets.businessinsider.com

    The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

    Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…

  • Top Healthcare Stocks to Watch for 2021
    stockstotrade.com

    Top Healthcare Stocks to Watch for 2021

    Check out Top Healthcare Stocks to Watch for 2021 by Bohen's team at StocksToTrade read more.

  • Boston Scientific (BSX) Watchman FLX Sales to Aid Q2 Earnings
    zacks.com

    Boston Scientific (BSX) Watchman FLX Sales to Aid Q2 Earnings

    Strong procedure recovery and market share gains across many of the businesses and regions are expected to have boosted Boston Scientific's (BSX) Q2 sales.

  • Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
    zacks.com

    Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

    Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

ETFs die in Boston Scientific investieren

Dir gefallen die Informationen zu Boston Scientific?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Boston Scientific?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Boston Scientific?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Boston Scientific?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic